CCBL2 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.07370001778406E-09 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.52989999999431E-06 |
Normal-vs-Stage2 |
3.815900E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
4.147700E-02 |
Stage1-vs-Stage2 |
8.064800E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
6.936400E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
6.263800E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.86860005036272E-09 |
Normal-vs-AfricanAmerican |
3.473200E-01 |
Normal-vs-Asian |
9.249600E-02 |
Caucasian-vs-AfricanAmerican |
5.480200E-01 |
Caucasian-vs-Asian |
8.476200E-01 |
AfricanAmerican-vs-Asian |
3.318400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.62429999999559E-05 |
Normal-vs-Female |
1.24850000005061E-06 |
Male-vs-Female |
3.577900E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.957120E-03 |
Normal-vs-Extreme_Weight |
2.54050000003669E-06 |
Normal-vs-Obese |
2.337600E-02 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
2.235700E-02 |
Normal_Weight-vs-Obese |
2.488600E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
7.064600E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.953800E-01 |
Normal-vs-Age(41-60Yrs) |
1.535450E-03 |
Normal-vs-Age(61-80Yrs) |
1.8775999999221E-07 |
Normal-vs-Age(81-100Yrs) |
5.667800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.166400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.918620E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.989600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.017600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.485400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.889600E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
6.108100E-02 |
Normal-vs-Grade 3 |
6.554100E-02 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
1.098160E-01 |
Grade 2-vs-Grade 4 |
6.108100E-02 |
Grade 3-vs-Grade 4 |
6.554100E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
7.4203999944622E-08 |
Normal-vs-N1 |
7.760200E-02 |
N0-vs-N1 |
8.883800E-01 |
|
|